We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) is one of the best psychedelic stocks on our list.
TheFly reported on June 25 that NRXP issued a statement responding to claims made by Kadima Neuropsychiatry Institute regarding the failed acquisition of Kadima by HOPE Therapeutics, a majority-owned subsidiary of NRx. The company stated that it had initiated arbitration proceedings over Kadima’s failure to satisfy key transaction requirements, including asset ownership verification and business condition obligations. NRXP said management believes pursuing the acquisition would not benefit patients or shareholders and emphasized that HOPE’s strategy remains focused on developing advanced treatments for depression, PTSD, and other serious conditions. The company also highlighted ongoing initiatives involving neuronavigated TMS technology, neuroplastic medicines, and partnerships supporting its evolving personalized medicine approach.
In other news, on June 22, NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) announced that the FDA approved an Intermediate Population Expanded Access Protocol for NRX-101, a fixed-dose combination of D-cycloserine and lurasidone, to support its use alongside accelerated Transcranial Magnetic Stimulation (TMS). The program is intended to provide access to NRX-101 through FDA-authorized compassionate use pathways for patients unable to participate in the company’s pivotal trial. NRXP stated that the initiative supports broader evaluation of the therapy’s potential to improve TMS outcomes. The company also highlighted its upcoming SPARC-TMS pivotal trial, which will assess the combination’s ability to address depression remission and suicidality in patients with treatment-resistant depression.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) is a clinical-stage biopharmaceutical company developing CNS therapies for severe mental health conditions, including suicidal depression, bipolar depression, and PTSD.
While we acknowledge the risk and potential of NRXP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NRXP and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.
